The FDA has approved the first at-home nasal spray flu vaccine, FluMist, allowing Americans to receive flu protection without ...

Michigan offers FluMist nasal vaccine delivery, aiming to increase flu vaccinations with the convenience of home administration for individuals aged 2 to 49.

Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, AppLovin, and Nvidia. The Motley Fool recommends AstraZeneca Plc. The Motley ...

The approval of the new nasal spray comes ahead of this year's influenza season in hopes to prevent the unusually high ...

As summer draws to a close, AstraZeneca has introduced a new way to fight the flu with the launch of FluMist Home.

FluMist, the first self-administered flu vaccine spray, is now available for purchase. Here's everything to know, from cost ...

If you are in one of 34 states, you can now order AstraZeneca's FluMist Home vaccine online to be delivered to your home ...

Getting kids vaccinated before school may be a little easier now as AstraZenica has launched a new at-home flu vaccine.

There's a new way to get the flu vaccine for anyone afraid of needles as AstraZeneca reveals the only FDA-approved nasal ...

According to SDIC Securities, the global AI-driven drug market has more than doubled since 2021, hitting $1.76 billion in 2024, with a compound annual growth rate of more than 30 percent.

Doctors are hoping that the first nasal flu vaccine available for use at home can improve vaccination rates among people who ...

AstraZeneca’s Flumist, which has Food and Drug Administration approval, can now be home-delivered to people in 34 states ...